People who receive AstraZeneca’s COVID-19 vaccine have a slightly increased risk of bleeding problems, according to a study published June 9 in Nature Medicine. Researchers observed adults in Scotland ...

FDA advisory panel backs AstraZeneca’s Truqap as the first targeted therapy for PTEN deficient metastatic hormone sensitive prostate cancer. The same panel issues a negative vote on breast cancer drug ...

FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new drugs that the Anglo-Swedish drugmaker plans to launch if the nation sticks ...

AstraZeneca has fired another volley in its bladder cancer competition with Merck’s Keytruda, with the FDA on Thursday ...

AstraZeneca (LSE:AZN) received US FDA approval for IMFINZI (durvalumab) with BCG therapy in BCG naïve, high risk non muscle invasive bladder cancer, based on positive Phase III data showing a ...

Start a conversation with TipRanks’ trusted, data-backed investment intelligence Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds AstraZeneca’s ...

AstraZeneca has robustly defended its vaccine, saying Friday there was "no evidence of an increased risk" of blood clots, and European and UK medicines regulators have each said the link between the ...

A multi-million-pound landmark "vaccine damage" case is set to take place in London's High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: An AstraZeneca logo is pictured in Brussels (Reuters) -AstraZeneca's COVID-19 prevention therapy reduced the risk of ...